Cannell & Spears’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-964
Closed -$213K 461
2026
Q1
$213K Buy
964
+1
+0.1% +$245 ﹤0.01% 395
2025
Q4
$244K Hold
963
﹤0.01% 376
2025
Q3
$238K Buy
963
+26
+3% +$6.22K ﹤0.01% 371
2025
Q2
$225K Hold
937
﹤0.01% 355
2025
Q1
$212K Buy
+937
New +$206K ﹤0.01% 363
2024
Q4
Sell
-935
Closed -$227K 421
2024
Q3
$227K Hold
935
﹤0.01% 370
2024
Q2
$205K Hold
935
﹤0.01% 350
2024
Q1
$210K Hold
935
﹤0.01% 360
2023
Q4
$206K Hold
935
0.02% 207
2023
Q3
$205K Hold
935
0.02% 198
2023
Q2
$210K Buy
+935
New +$187K 0.02% 212

Other funds holding STE

Cannell & Spears's STE Position: Q2 2026 in Review

Cannell & Spears sold out of Steris (STE) in Q2 2026, closing a stake of 964 shares — an estimated $213K sold.

Cannell & Spears first reported a position in STE in Q2 2023 and held it in 11 quarters. The position peaked at $244K in Q4 2025. 834 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Cannell & Spears reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
  • Cannell & Spears sold 964 Steris shares in Q2 2026, an estimated $213K.
  • Cannell & Spears first reported a position in Steris in Q2 2023 and held it in 11 quarters.
  • Cannell & Spears's Steris position peaked at $244K in Q4 2025.
  • 834 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.